This is the first case report of exacerbation of tracheobronchitis due to nontoxigenic corynebacterium diphtheriae in which tracheal pseudomembrane was identified and oral erythromycine therapy was very successful. (Internal Medicine 35: 650-652, 1996) Key words: sinobronchial syndrome (SBS), mucociliary transport, pseudomembrane, erythromycin (EM), and low dose and long term EMtherapy
rhinoscopy revealed mucopurulent postnasal drip and nasal polyps. The laboratory data on admission were as follows. White blood cell count was 3,200/jnl; erythrocyte sedimentation rate, 28 mm/hr; CRP 0.2 mg/dl. Serum IgG 2433 mg/dl, IgA 735 mg/dl, IgM 195 mg/dl, IgE 197 mg/dl, and cold hemagglutination xl28 were determined. The CPKlevel was 37 IU// and the electrocardiogram was normal. Chest X-ray revealed no significant findings. Bronchoscopy on admission revealed diffuse tracheobronchitis and grayish fibrinous exudate over the tracheal mucosa fromjust below the vocal cord to the first carina ( Fig. 1) . It was very thick and blocked the lumen of the airway. It was difficult to remove by suction and the biopsy specimens revealed no bronchial neoplasm. Based on these findings we tentatively diagnosed this case as tracheal tuberculosis ( 1 ) complicated with chronic sinobronchitis, which we call sinobronchial syndrome (SBS) (2) in Japan. The patient began taking oral erythromycin (EM) 600 mga day (low dose, long-term erythromycin therapy) (3, 4) for SBS and lg cephazolin sodium (CEZ) intravenously every 12 hours only for 2 days for prophylaxis of iatrogenic infection following bronchoscopy. Fromthe smear of sputum and bronchial lavage fluid we detected gram-positive rods and Klebsiella ozaenae but did not detect Mycobacterial species. After 3 days of oral erythromycin therapy, she recovered fromsevere illness and on day 5 of hospitalization her complaints were almost completely relieved. On day 7 follow-up bronchoscopy revealed only mild tracheobronchitis, no grayish exudate, and no stenotic lesions. On the same day, the gram-positive rods cultured from bronchial lavage fluid obtained on admission were proven to be Corynebacterium diphtheriae (mitis).
Biological characteristics of the bacteria were as follows:
glucose (+), maltose (+), sucrose weakly (+), lactose (-), mannitol (-), xylose (-), urease (-), nitrate reduction (-), esculin (+), catalase (+), motility (-), betahemolysis weakly (+), and metachromatic granules (+) were determined. The minimum inhibitory concentrations (MIC) of EMand CEZ against the isolated organism were 0.05 and 0.39 jig/ml respectively. The MICof CEZagainst Klebsiella ozaenae were previously reported as 6.25 jug/ml (5 Exacerbation of Bronchitis due to Diphtheriae Figure 1 . Grayish pseudomembranecovering tracheal mucosa, documented by bronchoscopy on admission.
at the outpatient clinic.
Discussion
Diphtheria is an acute, contagious, febrile illness caused by C. diphtheriae (6). The disease is characterized by a combination of local inflammation with pseudomembraneformation of the oropharynx and damageto the heart and peripheral nerves caused by action of its potent exotoxin. An association between complete immunization of the population and a decrease in the incidence of diphtheria has been noted in developed countries (7) . Nontoxigenic strains of C. diphtheriae are commonly isolated from carriers, particularly during a diphtheria outbreak. Such strains maycause pharyngitis but do not produce the systemic manifestation of diphtheria.
The term of sinobronchial syndrome (SBS) (2) is commonly used by Japanese thoracic physicians, is defined as a coexisting pathology of chronic sinusitis and nonspecific inflammatory lesion of the lower airway (e.g. chronic bronchitis, diffuse bronchiectasis, diffuse panbronchiolitis). Nondiphtherial corynebacteria have been reported rather than C. diphtheriae because they are causative organisms of severe infection in both the immunocompromised and immunocomponenthosts (8-11).
The present case is the first report of exacerbation f tracheobronchitis due to nontoxigenic C. diphtheriae in a healthy woman. It was diagnosed by bronchoscopy and bacteriological examination of bronchial lavage fluid. Dobie et al ( 1 2) reported clinical features of 44 culture-confirmed cases of diphtheria involving the respiratory tract. Sore throat was present in almost all patients and it was the chief complaint in 71%of the cases.
Less frequently encountered symptoms were dyspnea, nasal obstruction, and hemoptysis. Twenty-three (54.8%) of 42 patients had a diphtheric membrane. A tracheobronchial membrane was found at autopsy in three cases, but was not identified before death in any patient. Judging from the above, the present case is an unusual diphtheria. Whenacute exacerbation of chronic bronchitis due to commonbacterias such as Klebsiella pneumoniae, elevation of inflammatory markers such as WBC,CRPand ESR are generally observed. But in the present case these markers were almost normal and the patient did not reveal systemic manifestation. Weoffer here two reasons whyour case differed from the ordinary exacerbation of tracheobronchitis due to other common bacterias and C. diphtheriae. Here, the diphtheria was nontoxigenic, the bacteria did not invade the submucosal tissue (6) and there was no systemic manifestation, only local inflammation of trachea. This might be a distinct character of exacerbation of tracheobronchitis due to nontoxigenic C. diphtheriae. The immunological effects of some macrolides have been reported (13) . Recently at the 42th Japanese Congress of Chemotherapy Kobayashi et al (not published results) demonstrated that erythromycin inhibits the production of alginate which is responsible for the formation of biofilm in the mucoid morphotypeof Pseudomonas aeruginosa. The production of alginate is ultimately responsible for the poor prognosis and high motality rates among patients with cystic fibrosis (14) as well as SBS. The prognosis of SBS however, especially that of DPB, is now good, since long-term, low dose erythromycin therapy (3, 4) has been proven to be excellent. Though antibiotic therapy seemed to be very successful in the present case, it is questionable whether both total intravenous administration dosage of cephazolin sodium 4g and oral erythromycin 600mg daily had a sufficient antibiotic effect on the bacteria. The reason whythe pseudomembranedominated the trachea and there were no significant lesions in the upper airway, we suppose, is that mucosal damage including insufficiency of mucociliary transport (3) associated with SBSwas involved. In fact although she is free of lower airway symptoms, Pseudomonasaeruginosa and Klebsiella ozaenae were frequently recovered from her sputum at the outpatient clinic. As Klebsiella ozaenae was detected in her initial BALFand sputum coexisting C. diphtheriae we claim priority in reporting an association between exacerbation of tracheobronchitis and nontoxigenic C. diphtherae. Though there is no conclusive evidence, we suggest that colonization of nontoxigenic C. diphtheriae mitis was the a sole exacerbating factor and that low dose EMtherapy was very successful in this case.
